Becton Dickinson
- Revenue$20.2 BFY, 2021
- Market Capitalization$73.1 B2022-05-27
OverviewSuggest Edit
Becton, Dickinson and Company (BD) is a global medical technology company that develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products. It operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment offers medication delivery and management solutions, diabetes care products, and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products. The company serves healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public.
| Type | Public | |
| Founded | 1897 | |
| HQ | Franklin Lakes, NJ, US | Map |
| Website | bd.com | |
| Employee Ratings | ||
| Overall Culture | A- | More |
Recent NewsAll News
- BD and Mitsubishi Gas Chemical have signed a letter of intent (LOI) to discuss a partnership agreement to explore new ways to advance biologic drug delivery
- Worldwide COVID-19 Testing Industry Report 2022 - Featuring Abbott Laboratories, Becton Dickinson, bioMerieux and Danaher Among Others
- Babson, BD Expand Strategic Partnership to Advance Diagnostic Blood Collection in New Care Settings
- BD Announces Inaugural Members of Scientific Advisory Board
Key People/Management at Becton Dickinson
Simon D. Campion
Christopher Delorefice
Tony Ezell
Jerry Flasz
James Lim
Roland Goette
Becton Dickinson Office Locations
Becton Dickinson Financials and Metrics
Becton Dickinson Revenue
| USD | |
|---|---|
Revenue (Q1, 2022) | 5.0b |
Gross profit (Q1, 2022) | 2.4b |
Gross profit margin (Q1, 2022), % | 48.5% |
Net income (Q1, 2022) | 677.0m |
EBIT (Q1, 2022) | 815.0m |
Market capitalization (27-May-2022) | 73.1b |
Closing stock price (27-May-2022) | 256.5 |
Cash (31-Dec-2021) | 1.9b |
EV | 88.6b |
| USD | FY, 2019 |
|---|---|
EV/EBIT | 49.5 x |
EV/CFO | 26.2 x |
EV/FCF | 36.7 x |
Revenue/Employee | 246.7k |
Debt/Equity | 0.9 x |
Debt/Assets | 0.4 x |
Financial Leverage | 2.5 x |
P/E Ratio | 64.2 |
Becton Dickinson Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| Cytognos | January 31, 2022 | |
| Scanwell Health Inc. | December 20, 2021 | |
| Tissuemed, Ltd. | December 08, 2021 | |
| Venclose, Inc. | December 01, 2021 | |
| Tepha, Inc. | July 26, 2021 | |
| Velano Vascular | July 19, 2021 | |
| GSL Solutions | March 03, 2021 | |
| Cubex | November 12, 2020 | |
| Straub Medical AG | May 18, 2020 | |
| NAT Diagnostics, Inc. | May 08, 2020 |
Becton Dickinson Revenue Breakdown
Becton Dickinson revenue breakdown by business segment: 46.8% from Medical, 20.9% from Interventional and 32.3% from Life Sciences
Becton Dickinson revenue breakdown by geographic segment: 23.5% from EMEA, 16.2% from Greater Asia, 54.2% from United States and 6.2% from Other
Human Capital Metrics
Becton Dickinson Cybersecurity Score
Becton Dickinson Environment, Social & Governance (ESG) Ratings
Becton Dickinson Online and Social Media Presence
12.99k Twitter followers
Becton Dickinson has 12.99k Twitter Followers. The number of followers has increased 1.2% month over month and increased 3% quarter over quarter
Becton Dickinson's Trends
Twitter Engagement Stats for @BDandCo
4.2k
Tweets
708
Following
13k
Followers
54
Tweets last 30 days
4.6
Avg. likes per Tweet
90.7%
Tweets with engagement
Becton Dickinson Company Culture
Overall Culture
A-
75/100
CEO Rating
A+
81/100
Compensation
B+
75/100
Diversity
B
71/100
Becton Dickinson News and Updates
BD and Mitsubishi Gas Chemical have signed a letter of intent (LOI) to discuss a partnership agreement to explore new ways to advance biologic drug delivery
Worldwide COVID-19 Testing Industry Report 2022 - Featuring Abbott Laboratories, Becton Dickinson, bioMerieux and Danaher Among Others
Babson, BD Expand Strategic Partnership to Advance Diagnostic Blood Collection in New Care Settings
BD Announces Inaugural Members of Scientific Advisory Board
BD Named to Forbes' 2022 List of Best Employers for Diversity
Becton Dickinson Frequently Asked Questions
When was Becton Dickinson founded?
Becton Dickinson was founded in 1897.
Who are Becton Dickinson key executives?
Becton Dickinson's key executives are Simon D. Campion, Christopher Delorefice and Tony Ezell.
How many employees does Becton Dickinson have?
Becton Dickinson has 75,000 employees.
What is Becton Dickinson revenue?
Latest Becton Dickinson annual revenue is $20.2 b.
What is Becton Dickinson revenue per employee?
Latest Becton Dickinson revenue per employee is $270 k.
Who are Becton Dickinson competitors?
Competitors of Becton Dickinson include B. Braun, Cardinal Health and 10X Genomics.
Where is Becton Dickinson headquarters?
Becton Dickinson headquarters is located at Howe Buidling, 1 Becton Dr, Franklin Lakes.
Where are Becton Dickinson offices?
Becton Dickinson has offices in Franklin Lakes, Andover, Billerica, Broken Bow and in 84 other locations.
How many offices does Becton Dickinson have?
Becton Dickinson has 93 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies